Atlas Trials

Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD

Clinical trial NCT00527423 · COMPLETED

Trial details

NCT number
NCT00527423
Sponsor
Regeneron Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Macular Degeneration
Start date
2007-08-01
Primary completion
2011-10-01
Enrollment
157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.